Evicenter
Skyrizi (risankizumab-rzaa) in Plaque psoriasis
Manufacturer
AbbVie Inc.
Prescribing information
Skyrizi (opens in a new tab)
Questions
47
Last updated

All questions

Pharmacology: Skyrizi (risankizumab-rzaa) in plaque psoriasis

3 questions · 2 sources

Mechanism

How does Skyrizi work (mechanism of action)?

Pharmacokinetics

How long does Skyrizi stay in your system (half-life)?

Components

What are the inactive ingredients in Skyrizi?

Note: The first passage, from the Medication Guide, covers every presentation. The second gives the amounts per unit for the presentations used for plaque psoriasis: the 55 mg/0.37 mL prefilled syringe and the 150 mg/mL prefilled pen and syringe.